Father-son team snag $60M for East Bay biotech startup after big Amgen buyout last year

The startup has three drugs — targeting cancer, inflammation and hepatitis B — that were split off from its founders' previous companies buyout by Amgen.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news